Matthew Zachary joins Humanity Rx to break down how modern cancer care improves survival while leaving patients exposed to medical debt, prior authorization delays, and financial risk, and why policy change depends on organized patient power.

Women were excluded from U.S. clinical trials until 1993. That decision shaped drug safety, outcomes, and cost for decades. This essay breaks down the incentives, capital flows, and regulatory gaps that sustained it and what must change next.

Express Scripts allegedly created a Swiss shell company to hide rebate money from employers and patients. Cigna's own CMO admitted they could "double, triple dip on fees." Now a RICO lawsuit threatens existential damages. Welcome to 2026: The Year of the Patient.

Monique Gore Massy spent 2.5 years misdiagnosed while lupus shut her body down. This episode exposes bias, diagnostic delay, and the cost of dismissing patients who “look fine,” and what happens when lived experience demands real authority.

When an insurer labels trigeminal nerve blocks investigational, patients may face brain surgery instead. This essay examines how coverage policy, coding decisions, and actuarial incentives shape care for trigeminal neuralgia and what must change to align patient protection with economic logic.

Gallup reports 82 million Americans cut back on daily life to afford healthcare. Coverage shifts financial risk to families through deductibles and prior authorization. Diagnosis now operates like a private tax on survival and forces tradeoffs across work, housing, and retirement.

I do not have insider sources. I have Google Alerts. Set up 19 targeted alerts and watch insurance denials, cancer treatment delays, lawsuits, and settlements roll in daily. The stories are public. The patterns are obvious. Here is how to see what I see.

At 25, cervical cancer forced Tamika Felder into a hysterectomy without fertility preservation. Two decades later, another survivor donated embryos that helped her become a mother. A story about systemic gaps, advocacy, and the family she built anyway.

Sally Neely Nix manages chronic pain with nerve block injections. No opioids. Her insurer calls them experimental. So she built a policy brief and sent it to the CEO. While in extreme pain. Patients shouldn't have to become researchers to access care that works.

After 30 years of cancer survivorship, Matthew Zachary explains why he partnered with Codex Labs. This post explores radiation side effects, steroid driven treatment cycles, skincare regulation gaps, and why barrier focused science matters for compromised skin.

ER physician Dr Pamela Buchanan spent 20 years inside American medicine and 2020 nearly broke her. She worked 80 to 100 hour COVID weeks, isolated from family, and faced emotional flatline head on. A raw look at burnout, suicide risk, and why doctors are walking away.

After 22 years away from solo performance, Matthew Zachary returns to the stage April 28 at Merkin Concert Hall in NYC. A live piano concert marking 30 years since brain cancer, featuring stories from the cancer community and the launch of We the Patients.

Millions cycle through eczema treatments that calm symptoms but never fix the cause. This essay explains how payment models, regulation, and product marketing keep patients trapped in repeat care instead of long term prevention.

Dr Eugene Manley survived 20 to 30 ER visits a year in 1980s Detroit, earned 3 science degrees, and later caught falsified records after surgery at Mount Sinai Queens. In EP433 he breaks down medical racism, STEMM access, and how patients fight back with facts.

Mark Cuban walked into the Senate with spreadsheets and receipts. He called PBMs a cartel. He saved Medicare $2 billion. But math doesn't show up at town halls. Receipts don't vote. Here's the hole in his equation and an invitation to fix it.

Mark Cuban exposes PBM corruption and champions transparent drug pricing. He is right about generics. He is wrong about cash solving catastrophic care. A brain cancer survivor explains why $12 prescriptions and $960,000 transplants live in different universes.

In 2025, seven insurers generated $1.7 trillion in revenue and $54 billion in profit while covering 10 million fewer people. Premiums hit $26,993 for families. Public funding expanded. Consolidation deepened. The incentive structure driving American health insurance stands exposed.

Blue Cross Blue Shield settled a 2.67 billion antitrust lawsuit in 2020 after restricting competition for more than a decade. Payments begin in 2026. Six years later, customers get checks while insurers move on. Here is what happened and why it keeps happening.

Jenny Opalinski worked ICU floors where 10 to 15 traumatic events can hit in a single shift. In EP432 of Out of Patients she confronts clinician burnout, moral injury, and the cost of empathy in healthcare. A raw conversation about survival inside a system that grinds people down.

Matthew Zachary reads from We the Patients for the first time at the Cervivor Summit. Surrounded by cervical cancer survivors, he breaks down while honoring families crushed by medical debt and systemic failure. A defining moment ahead of the book’s May 2026 release.